Hong Kong Surpasses Switzerland as the Worlds Top Offshore Wealth Hub Walmart Warns US Shoppers Are Cutting Spending as Higher Fuel Costs Bite RBIs Surprise Rate Cut Dilutes Policy Framework Nomura Says Worker Confidence Plunges to Record Low Amid Rising AI Job Displacement Fears Global Survey Finds ECB Signals No Urgency to Counter Market Speculation on June Rate Hike NASA Selects Blue Origin for First Uncrewed Lunar Mission in 20 Billion Moon Base Plan Everest Group EG Q1 2026 Earnings EPS Surges Past Estimates on Strong Underwriting AIT Q1 2026 Earnings EPS Misses Estimates by a Narrow Margin Stock Edges Higher TAP Q1 2026 Earnings Stellar EPS Beat of 67 Surprises Analysts POWL Q1 2026 Earnings EPS Misses Estimates amid Operational Headwinds Shares Edge Higher QCOM Q1 2026 Earnings Earnings Beat Expectations Amid Strong Demand Shares Surge APRE Q1 2026 Earnings Narrower Loss Beats Estimates Stock Rises 215 Blue Owl Capital OBDC Slightly Down Holds Between Defined Support and Resistance Levels Eaton Vance Senior Income Trust EVF Edges Lower Amid Quiet Trading Support at 472 in Focus Oxford Square Capital Notes OXSQG Slides Slightly Amid FixedIncome Pressures Rail Vision RVSN Slides 44 as Shares Test Key Support Level Six Flags Entertainment FUN Modestly Higher as Stock Tests Key Support Zone Tech Giants Broadcom Meta and Others Invest 125 Million in UCLA Semiconductor Research Hub Everest Group EG Q1 2026 Earnings Strong EPS Beat Amid Resilient Underwriting Results Myers Industries MYE Surges 386 Approaching Resistance Amid Renewed Buying Interest Arrow Financial Corporation AROW Edges Higher as Bullish Momentum Builds IHS Holding Limited IHS Holds Steady Near Support as Telecom Infrastructure Stock Consolidates Apollomics Inc Warrant APLMW Stalls at 001 MicroCap Warrant Holds Steady Amid Minimal Trading Activity ING Group ING Slips Slightly Amid Mixed Sector Sentiment Key Levels in Focus Federated Hermes Premier Municipal Income Fund FMN Edges Higher Amidst Steady Trading First National Corporation FXNC Holds Steady Near Support as Modest Gains Signal Consolidation Chemomab Therapeutics CMMB Stages a Sharp Rebound Can the Biotech Sustain Its Upward Momentum